Publications by authors named "Ali Alsharqi"

Claim this Profile
S
Successful Use of Dupilumab in the Management of Recalcitrant Pemphigoid Gestationis.
Stephanie-Lynn Ryan, Ali Alsharqi

Australas J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observation of weight gain in patients with atopic dermatitis receiving dupilumab.
Darren Roche, Donal O'Shea, Brian Kirby, Ali Alsharqi

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Supervised Machine Learning Models to Logistic Regression Model Using Tooth-Related Factors to Predict the Outcome of Nonsurgical Periodontal Treatment.
Ali J B Al-Sharqi, Mohammed Taha Ahmed Baban, Nada K Imran, Sarhang S Gul, Ali A Abdulkareem

Diagnostics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Nonsurgical Periodontal Treatment of Periodontitis Stages 2 and 3 on Oral Health-Related Quality of Life.
Ali J B Al-Sharqi, Ali A Abdulkareem, Sarhang Gul, Andrew Rawlinson

Healthcare (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological and Salivary Biomarkers Successfully Predict Site-Specific and Whole-Mouth Outcomes of Nonsurgical Periodontal Treatment.
Ali Jb Al-Sharqi, Ali Abdulkareem

J Clin Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis.
Ali A Abdulkareem, Firas B Al-Taweel, Ali J B Al-Sharqi, Sarhang S Gul, Aram Sha

J Oral Microbiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from adalimumab originator to biosimilar: a 3-year retrospective cohort analysis.
Lisa Killion, Ali Alsharqi, Brian Kirby

Clin Exp Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.
Shan Pan, Teresa Tsakok, Nick Dand, Dagan O Lonsdale, Floris C Loeff, Ali Alsharqi

Clin Transl Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis.
Teresa Tsakok, Nina Wilson, Nick Dand, Floris C Loeff, Karien Bloem, Ali Alsharqi

JAMA Dermatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A baby with a widespread itchy rash.
Michael J Lavery, Deborah Woodcock, Will Simmons, Ali Al-Sharqi

BMJ· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.
Nick Dand, Michael Duckworth, David Baudry, Alice Russell, Charles J Curtis, Ali Alsharqi

J Allergy Clin Immunol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapy.
Nekma Meah, Ali Alsharqi, Richard M Azurdia, Lynne-Catherine Owens, Richard Parslew

Australas J Dermatol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Phototherapy in Children.
Karen Eustace, Sophie Dolman, Ali Alsharqi, Graham Sharpe, Richard Parslew

Pediatr Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatology consultations: how long do they take?
Junie Li Chun Wong, Rosie Catherine Vincent, Ali Al-Sharqi

Future Hosp J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recapturing adequate control of psoriasis by additional immunosuppressive agents alongside ustekinumab.
Prativa S Jayasekera, Richard A Parslew, Ali Al-Sharqi

JAAD Case Rep· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Craniofacial hyperhidrosis in post-menopausal women.
Ali Alsharqi, Niall J E Wilson

Australas J Dermatol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a benefit from using a subsequent anti-TNF α medication in psoriasis patients who failed their first or second anti-TNF α agent?
Ali Alsharqi, Richard Parslew, Bernadette Dever, Victoria Arslanian

Australas J Dermatol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A linear rash: a clinicopathological challenge. What is your diagnosis?
Ali Alsharqi, Richard Parslew

Int J Dermatol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 3-month-old with a blistering plaque.
Ali Alsharqi, Richard Parslew, Rajeev Shukla

Dermatol Online J· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eczema occurring after cutaneous injury.
Ali Alsharqi, Clodagh King, Kath Panting

Australas J Dermatol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals.
Makram M Al-Waiz, Ali I Al-Sharqi

Dermatol Surg· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis